|
|
|
|
|
|
|
|
the Ovarian Cancer Association Consortium
As ovarian cancer remains a highly fatal disease and the prevalence of obesity continues to increase, studies focusing on causal mechanisms involved in adverse survival are needed.
A recent meta-analysis of 14 studies concluded that women with ovarian cancer, who were obese, had 17% worse survival compared with those of normal weight (Protani et al, 2012). However, the studies in this meta-analysis varied greatly in the timing of obesity measurement: from usual adult weight to weight at the time of diagnosis, or at the commencement of chemotherapy. Most of the studies included had a relatively small sample size (median=301) and, as a consequence, variation by histologic subtype could not be investigated. Furthermore, few studies had examined progression-free survival (PFS) or ovarian cancer-specific survival.
Among the 21 OCAC studies, 756 (5.3%) women were with missing BMI information. Of the 12 390 women included in the analyses, BMI ranged from 13.7 to 68.3 kg m−2. Three hundred and seven women were underweight (BMI <18.5) and 71 (0.6%) had BMI values >50 kg m−2.Background:
Observational
studies have reported a modest association between obesity and risk of
ovarian cancer; however, whether it is also associated with survival and
whether this association varies for the different histologic subtypes
are not clear. We undertook an international collaborative analysis to
assess the association between body mass index (BMI), assessed shortly
before diagnosis, progression-free survival (PFS), ovarian
cancer-specific survival and overall survival (OS) among women with
invasive ovarian cancer.
Methods:
We used original data from 21 studies, which included 12 390
women with ovarian carcinoma. We combined study-specific adjusted
hazard ratios (HRs) using random-effects models to estimate pooled HRs
(pHR). We further explored associations by histologic subtype.......
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.